How severe is CVE-2022-46333?

CVE-2022-46333 has a CVSS 3.x base score of 7.2, rated high severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-46333 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (71st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-46333?

CVE-2022-46333 affects Proofpoint Enterprise Protection. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-46333?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-46333 published?

CVE-2022-46333 was published on 2022-12-06 and last updated on 2026-06-17.

CVE-2022-46333

CVE-2022-46333 is a high-severity vulnerability in Proofpoint Enterprise Protection with a CVSS 3.x base score of 7.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Severity: High (CVSS 3.x base score 7.2)
EPSS exploit prediction: 1% (71st percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-94
Affected product: Proofpoint Enterprise Protection
Published: 2022-12-06
Last modified: 2026-06-17

Description

The admin user interface in Proofpoint Enterprise Protection (PPS/PoD) contains a command injection vulnerability that enables an admin to execute commands beyond their allowed scope. This affects all versions 8.19.0 and below.

Frequently asked questions

What is CVE-2022-46333?: The admin user interface in Proofpoint Enterprise Protection (PPS/PoD) contains a command injection vulnerability that enables an admin to execute commands beyond their allowed scope. This affects all versions 8.19.0 and below.
How severe is CVE-2022-46333?: CVE-2022-46333 has a CVSS 3.x base score of 7.2, rated high severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-46333 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (71st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-46333?: CVE-2022-46333 affects Proofpoint Enterprise Protection. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-46333?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-46333 published?: CVE-2022-46333 was published on 2022-12-06 and last updated on 2026-06-17.

References

https://www.proofpoint.com/security/security-advisories/pfpt-sa-2022-0003

Affected products (1)

cpe:2.3:a:proofpoint:enterprise_protection:*:*:*:*:*:*:*:*

More vulnerabilities in Proofpoint Enterprise Protection

CVE-2023-0090 — Critical (CVSS 9.8): The webservices in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows for an anonymous user…
CVE-2022-46332 — Critical (CVSS 9.6): The Admin Smart Search feature in Proofpoint Enterprise Protection (PPS/PoD) contains a stored cross-site scripting…
CVE-2023-0089 — High (CVSS 8.8): The webutils in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows an authenticated user to…
CVE-2019-19680 — High (CVSS 8.8): A file-extension filtering vulnerability in Proofpoint Enterprise Protection (PPS / PoD), in the unpatched versions of…
CVE-2022-46334 — High (CVSS 7.8): Proofpoint Enterprise Protection (PPS/PoD) contains a vulnerability which allows the pps user to escalate to root…
CVE-2021-39304 — High (CVSS 7.5): Proofpoint Enterprise Protection before 8.12.0-2108090000 allows security control bypass.

All CVEs affecting Proofpoint Enterprise Protection →

Other CWE-94 (Code Injection) vulnerabilities

CVE-2026-57624 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Blocksy Companion Pro <= 2.1.46 versions.
CVE-2026-10134 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 allows an attacker to read every secret available to the Langflow process, read…
CVE-2026-53576 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, the authentication filter…
CVE-2026-10561 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 has an vulnerability due to an improper isolation of Python execution combined…
CVE-2026-25470 — Critical (CVSS 10.0): Improper Control of Generation of Code ('Code Injection') vulnerability in ACPT ACPT (Pro) - Custom Post Types Plugin…
CVE-2026-48836 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Easy Invoice <= 2.1.19 versions.

Browse all CWE-94 (Code Injection) vulnerabilities →